Nutrition Therapy in Adult Patients Requiring ECMO in Australia and New Zealand
NCT02048046 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109
Last updated 2014-01-29
Summary
Patients with heart and/or lung failure are some of the sickest patients in our hospital systems. In severe cases they often need long periods of specialist care in Intensive Care Units (ICU) in Australia and New Zealand. Extracorporeal Membrane Oxygenation (ECMO) is an extremely specialised and costly form of life support, only being utilised when a patient is close to death as a last resort to save their life. This form of life support has been used for many years in babies and children but is relatively new for adults. Whilst there is evidence emerging of the positive effects of ECMO in adults, there is a lot that is unknown and further research is required.
Another essential therapy that assists patients in their recovery from illness is the provision of artificial nutrition. This liquid formula is delivered into the stomach or as a nutritionally rich fluid provided into the vein. Until recently nutrition was under-emphasised in the critically ill, however, it has now become clear that targeted nutrition can positively affect a person's outcome and is vital during long periods of intensive care hospitalisation.
There is very limited data on how nutrition affects the outcomes of ECMO patients (positive or negative). We know from limited studies that these patients receive less nutrition than other patients, something that is particularly concerning given that less nutrition leads to a longer hospital stay and has been linked a with higher hospital mortality. We also think that adult patients on ECMO need more nutrition as they appear to lose more weight than patients with other illnesses in intensive care; however this has not been confirmed. It is thus essential that we understand the effects of this relatively simple but vital therapy on these very sick patients.
This study proposes to collect information on the current feeding practices in patients on ECMO and describe the factors that inhibit or allow provision of nutrition so that we can understand the issues that exist, develop strategies to improve delivery of nutrition and determine areas for further research.
Conditions
- Patients on Extracorporeal Membrane Oxygenation
Sponsors & Collaborators
-
Australian and New Zealand Intensive Care Research Centre
lead OTHER
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2013-06-30
Countries
- Australia
- New Zealand
Study Locations
More Related Trials
-
Extracorporeal Membrane Oxygenation for Respiratory Failure Patients
NCT06231446 ·Status: RECRUITING
-
Blend to Limit Oxygen in ECMO: A Randomised Controlled Registry Trial
NCT03841084 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Nutritional Support of Critically Ill Patients Requiring Mechanical Ventilation
NCT00256074 ·Status: TERMINATED ·Phase: NA
-
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
NCT05562505 ·Status: RECRUITING ·Phase: NA
-
Early Goal-Directed Sedation Compared With Standard Care in Mechanically Ventilated Critically Ill Patients
NCT01728558 ·Status: COMPLETED ·Phase: PHASE3
-
Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS)
NCT01669863 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients
NCT02859194 ·Status: COMPLETED ·Phase: NA
-
Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure: the NHS ECMO Study.
NCT03979222 ·Status: COMPLETED
-
ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure
NCT04031794 ·Status: UNKNOWN
-
Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure
NCT01468142 ·Status: COMPLETED
-
Pharmacokinetics in Extracorporeal Membrane Oxygenation
NCT03766282 ·Status: UNKNOWN
-
TEAM: Trial of Early Activity and Mobilization
NCT01674608 ·Status: COMPLETED
-
Predictors of Non-invasive Ventilation Failure in Patients With Acute Cardiogenic Pulmonary Edema
NCT02653365 ·Status: COMPLETED
-
Generating Evidence in ECMO Ventilation Strategies
NCT05708365 ·Status: COMPLETED ·Phase: NA
-
The Augmented Versus Routine Approach to Giving Energy Trial
NCT02306746 ·Status: COMPLETED ·Phase: PHASE3
-
CONTINUation of Enteral Nutrition Prior to Extubation Compared to Standard Care
NCT06382727 ·Status: COMPLETED ·Phase: NA
-
Extra Corporeal Membrane Oxygenation in the Acute Respiratory Distress Syndrome: Utility of a Biomarker to Assess the Membrane Efficiency in Improving Oxygenation
NCT02879344 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Alterations During ECMO
NCT01938079 ·Status: COMPLETED ·Phase: NA
-
The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO
NCT04708457 ·Status: COMPLETED ·Phase: NA
-
Assessing Diaphragm Muscle Inactivity in Mechanically Ventilated ICU Patients
NCT02434016 ·Status: COMPLETED
-
Biomarkers, Genomics, Physiology in Critically Ill and ECMO Patients
NCT04669444 ·Status: UNKNOWN ·Phase: NA
-
Mechanism of Nitric Oxide on Ventilator-induced Diaphragm Dysfunction with Extracorporeal Membrane Lung Assistance
NCT06660784 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Mechanical Insufflation-Exsufflation in Preventing Respiratory Failure After Extubation
NCT01424202 ·Status: COMPLETED ·Phase: NA
-
Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
NCT04343404 ·Status: COMPLETED
-
Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China
NCT03345758 ·Status: UNKNOWN